MARKET

EBS

EBS

Emergent Bio
NYSE

Real-time Quotes | Nasdaq Last Sale

52.47
-0.11
-0.21%
After Hours: 52.47 0 0.00% 16:22 10/14 EDT
OPEN
52.29
PREV CLOSE
52.58
HIGH
52.75
LOW
51.79
VOLUME
116.49K
TURNOVER
--
52 WEEK HIGH
73.89
52 WEEK LOW
39.11
MARKET CAP
2.71B
P/E (TTM)
-119.6579
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EBS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

EBS News

  • Emergent's Chikungunya Vaccine Candidate Gets EMA's PRIME Tag
  • Zacks.3d ago
  • Emergent Bio receives PRIME designation for chikungunya virus VLP vaccine candidate
  • seekingalpha.4d ago
  • New Stocks on the Argus Focus List
  • Yahoo Finance.4d ago
  • Emergent BioSolutions Receives EMA Prime Designation for Its Chikungunya Virus VLP Vaccine Candidate
  • GlobeNewswire.4d ago

More

Industry

Pharmaceuticals
-0.01%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About EBS

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).
More

Webull offers Emergent Biosolutions Inc (EBS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.